Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.

Clinical trial NCT01233843 · COMPLETED

Trial details

NCT number: NCT01233843
Sponsor: Groupe Oncologie Radiotherapie Tete et Cou
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Head and Neck Carcinoma

Start date: 2009-05-18
Primary completion: 2018-11-06
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.